Powered by
-
BIIB Stock Chart
Historical BIIB Prices
Biogen Stock Analysis
Rating: Hold
Total Grade: C
Analysis Breakdown
| BIIB Stock Grade: | C |
| Fundamental Grade: | C |
| Quantitative Grade: | C |
| BIIB Earnings | |
| Earnings Growth: | D |
| Earnings Momentum: | F |
| Earnings Surprises: | B |
| Analyst Earnings Revisions: | B |
| BIIB Financial Information | |
| Sales Growth: | C |
| Operating Margin Growth: | D |
| Cash Flow: | B |
| Return on Equity: | A |
Biogen Stock: Weekly View
| This Week: | C |
|---|---|
| Last Week: | C |
| Two Weeks Ago: | C |
BIIB Stock predictions, Articles, and Biogen News
- From InvestorPlace
- From the Web
-
Why Every Investor Should Hold Shares of Biogen Stock - July 25, 2018
Biogen reported solid study results for its Alzheimer's study and followed up with a solid quarterly earnings report. BIIB stock is a clear core holding for investors. Continue…
-
5 Top Stock Trades for Tuesday — Buy, Sell or Hold Tesla? - July 23, 2018
Micron pulled back into support, while Tesla tanked on worries over its methods for generating a profit. Here are our top stock trades for Tuesday. Continue…
-
Biogen Is the Right Alzheimer’s Stock … At the Wrong Time - July 10, 2018
BIIB stock jumped on Friday, and for good reason. It's not a buy at these lofty levels, but Biogen has at least earned a spot on your watchlist. Continue…
-
5 Top Stock Trades for Monday - July 8, 2018
Biogen soared 20% and gave a big lift to biotech stocks. IQiyi is finally coming back down to reasonable levels. Here are our top five stock trades for Monday. Continue…
-
Don’t Buy Biogen Stock on the Promise of an Alzheimer’s Breakthrough - July 6, 2018
Biogen announced that a drug that seemed to fail after 12 months had better results after 18, giving new hope for the "amyloid approach" to Alzheimer's Continue…
-
Biogen Inc Stock Shoots Higher on Alzheimer’s Drug Trial - July 6, 2018
Biogen (BIIB) stock was soaring today on positive results from a recent Alzheimer's drug trial conducted along with Eisai. Continue…
-
Biogen Inc Stock Got an Upgrade, but Should You Listen? - June 4, 2018
Analysts are buying into the recent resurgence of BIIB stock, but they may be ignoring serious fundamental headwinds. Here's a closer look at why investors should be cautious with Biogen Inc. Continue…
-
FDA Shame List: 40 Drug Makers That Try to Block Generic Drugs - May 18, 2018
The Food and Drug Administration (FDA) announced a list of drug makers that have tried to block generic drugs in its new shame list. Here they are. Continue…
-
The Good and the Bad News With Biogen Inc Earnings Results - April 30, 2018
Even before Biogen's quarterly report, BIIB stock sank after a series of disappointing clinical results. Investors have to weigh in the good and the bad developments ahead. Continue…
-
Here’s Why 275% in Biogen Inc Stock Looks Realistic - April 27, 2018
It’s not just as good as time as any to get long BIIB stock, it’s a better time than most using an October bull call spread. Continue…
